Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin
PharmacoEconomics - United Kingdom
doi 10.1007/s40273-018-0641-6
Full Text
Open PDFAbstract
Available in full text
Date
April 12, 2018
Authors
Publisher
Springer Science and Business Media LLC